KYLE M. DEVINS, MD

Plain English
This study looked at a rare kidney tumor called a-rearranged perivascular epithelioid cell tumor (PEComa), focusing on how it can be misdiagnosed. A 32-year-old man initially had a biopsy that was wrongly diagnosed as a type of kidney cancer, but further testing revealed it was actually a PEComa. Despite treatment, his cancer spread to the liver, emphasizing the need for careful diagnosis since these tumors can mimic other forms of cancer. Who this helps: This research benefits doctors by improving their ability to identify and treat rare kidney tumors.

Plain English
This research looked at a type of lesions called SMILEs and ISMCs found in the anal canal and their relationship to other types of cancer. The study identified 4 cases, revealing that 2 had SMILE, 1 had ISMC, and 1 had both, with connections to other types of cancer in 3 cases. Importantly, all patients were still alive after an average of 16.5 months, but one had a separate cancer diagnosis shortly after treatment. Who this helps: This study benefits patients and doctors by improving awareness and understanding of these lesions in the anal canal.

Plain English
This study looked at 10 rare and aggressive cases of anaplastic juvenile granulosa cell tumors (JGCT), which are different from typical JGCTs. The researchers found that these tumors were quite large, averaging 21 cm, and had significant genetic changes, including mutations in the TP53 gene and amplifications of the MYC gene in some cases. Four out of nine patients with follow-up died from their cancer, especially those with advanced tumors, highlighting the importance of recognizing these tumors as they require different treatment approaches. Who this helps: This information helps doctors treating patients with these rare tumors, allowing them to tailor their therapies more effectively.

Plain English
This study looked at a rare finding called isolated squamous morular metaplasia in tissue samples taken from the lining of the uterus. Out of more than 32,000 samples, only 57 had this condition, with a low risk of developing cancer later on—about 5.4% went on to show cancer in follow-up tests. This is important because it suggests that many patients might not need repeated tests if their initial follow-up shows no signs of cancer. Who this helps: Patients with isolated squamous morular metaplasia can avoid unnecessary repeat biopsies.

Plain English
This study looked at five cases of uterine teratomas, which are rare tumors that can contain various types of tissue. The tumors ranged in size from 2.4 to 6.5 cm, and most patients were between 29 and 60 years old. While some of the tumors were benign and showed no signs of disease after follow-up of up to 42 years, two tumors had features of immaturity that could indicate a need for concern, but further research is needed to understand the potential risks associated with them. Who this helps: This research benefits doctors and researchers by providing insights into uterine teratomas, helping them better diagnose and treat these rare tumors.

Plain English
Researchers studied a rare type of tumor called DICER1-related primitive polyphenotypic neoplasm, which can occur in the female reproductive system and abdomen. They found 15 cases of this tumor in patients aged 10 to 77, with many showing specific cell features that made them difficult to identify. Understanding these tumors is important because recognizing their unique characteristics can lead to better diagnosis and genetic testing, especially for younger patients who may have inherited risks.

Plain English
Researchers studied a type of ovarian and fallopian tube cancer with a unique appearance. They found that these tumors often lack a specific marker (PAX8) that is usually present in other cancers, but they commonly express another marker (SOX17) and have mutations in a gene (CTNNB1) that affect cell behavior. This understanding is important because it helps doctors correctly identify these tumors, preventing misdiagnosis and ensuring patients receive the right treatment.

Plain English
This study looked at SOX17, a new marker that can help identify certain cancers, and compared it to an older marker called PAX8 in both benign (non-cancerous) and malignant (cancerous) growths in the lining of the abdomen (mesothelium). Researchers found that SOX17 showed up in 25% of benign samples and 13% of mesotheliomas, while PAX8 was present in 40% of benign samples and also 13% of mesotheliomas. This matters because relying solely on SOX17 to diagnose gynecological cancers could lead to misdiagnosis since both markers do not perfectly identify the conditions they were supposed to differentiate. Who this helps: This helps pathologists who diagnose cancer by providing clearer guidelines on using these markers.

Plain English
This study looked at a specific protein called ORF1p, linked to a type of ovarian cancer known as clear cell ovarian carcinoma (CCOC). Researchers found that over 82% of CCOC tumors express this protein, which begins to show up early during the progression of the disease from endometriosis to cancer. The presence of ORF1p in the blood suggests it could be a useful, less invasive method for diagnosing CCOC early. Who this helps: This helps patients, particularly women at risk for clear cell ovarian carcinoma.

Plain English
This study looked at 40 cases of a rare type of cancer that can develop in an ovarian tumor known as a mature cystic teratoma (MCT). Out of over 2400 MCT cases, only 0.54% had this somatic malignancy, with types including squamous cell carcinoma and papillary thyroid carcinoma. The results showed that patients with early-stage cancers generally had better outcomes, but even some early-stage patients experienced recurrences, highlighting the importance of ongoing monitoring. Who this helps: This information helps patients and doctors in managing ovarian tumors and understanding potential cancer risks.

Plain English
This study looked at a rare type of ovarian tumor called juvenile granulosa cell tumor (juvGCT), which primarily affects children and teenagers. Researchers tracked 70 patients diagnosed between 2001 and 2024 and found that 81% had early-stage tumors (Stage I). The three-year survival rate varied by tumor stage, ranging from 48% for more advanced stages (II-IV) to 80.2% for the least severe stage (IA), indicating that younger patients with early-stage tumors generally have good chances of survival. Understanding these tumors better may help identify which patients need additional treatment and lead to new therapy options. Who this helps: This helps patients with juvenile granulosa cell tumors and their doctors.

Plain English
This study looked at the outcomes of patients with rare ovarian tumors called Sertoli-Leydig cell tumors (SLCTs) to see how certain genetic changes (germline variants) affected their survival. Among 162 patients, 60% had these genetic variants, and those patients had a better chance of not experiencing a tumor recurrence after three years (87.2%) compared to those without the variants (78.1%). Additionally, patients with the variants had higher overall survival rates over three years (93.9%) and five years (notably, 78.2% for those without the variants). Who this helps: This research benefits patients with SLCT by helping doctors understand their prognosis and the potential risks of further health issues.

Plain English
This study looked at how the presence and extent of lymphovascular invasion (LVI) affects the outcomes for patients with early-stage cervical squamous cell carcinoma. Researchers analyzed data from 426 patients and found that those with stage IB cancer and extensive LVI had significantly worse chances of surviving without progression (about 2.86 times worse) and overall survival (about 2.88 times worse) compared to those with little or no LVI. This is important because it suggests that measuring LVI can help doctors better predict how a patient might respond to treatment. Who this helps: Doctors and patients with early-stage cervical cancer.

Plain English
This study looked at a particular type of cervical cancer that isn't caused by the human papillomavirus (HPV) and compared it to the more common HPV-related cervical cancer. Researchers found that the HPV-independent cervical cancers had worse outcomes: patients were typically older (median age 68), had larger tumors, and experienced more frequent recurrences and lower survival rates compared to HPV-associated cancers. This research highlights the need for better testing and monitoring for these less common cancers, especially in older women. Who this helps: This benefits patients diagnosed with HPV-independent cervical cancer and their doctors by informing them about the severity and management of this disease.

Plain English
This study looked at 55 cases of unusual blood vessel growths in the upper female reproductive organs, finding that most were benign (42 cases) and some were cancerous angiosarcomas (13 cases). The benign lesions averaged around 2 cm in size and were often found incidentally, while the angiosarcomas had a larger average size of about 9.7 cm and a much younger average age of diagnosis at 32 years. Understanding these lesions is important because it helps identify which types are benign and their potential connections to other health issues, as the angiosarcomas tend to have a poor outlook with many patients not surviving long after diagnosis. Who this helps: This helps patients, particularly women diagnosed with vascular lesions in the reproductive system, and their doctors.

Plain English
This study looked at 102 patients with low-grade endometrial stromal sarcomas (LG-ESS), which are a type of cancer that affects the uterus. Researchers found that after five years, 80% were free from disease, and 94% were alive without any signs of cancer, though over ten years, these numbers dropped to 51% and 87%, respectively. Key findings showed that if a tumor invaded the cervical stromal area, patients had a worse chance of staying disease-free, indicating that certain tumor features could help doctors better understand a patient’s risk for recurrence. Who this helps: This information helps patients and doctors better manage the treatment and follow-up care for those with LG-ESS.

Plain English
This study looked at three cases of a type of uterine cancer known as endometrial stromal sarcoma, all of which had a specific genetic change called KDM2B gene fusions. Among the patients, one died from the disease within 29 weeks, while another had surgery and was still alive after 28 weeks, although her cancer's status is unknown. These findings suggest that this group of tumors may represent a new, more aggressive subtype of uterine sarcoma, which could influence treatment decisions in the future. Who this helps: This information benefits patients with uterine sarcomas and their doctors.

Plain English
Researchers studied a specific type of ovarian tumor known as adult granulosa cell tumors (AGCT) that showed features resembling both female and male cell types. They examined 80 cases and found that while these tumors primarily displayed characteristics typical of AGCT, they also contained unique tubular structures, which is unusual. This finding is significant because it helps clarify how these tumors are classified and suggests they may represent a distinct group, aiding in better diagnosis and treatment for patients.

Plain English
Researchers studied four unusual ovarian tumors with specific genetic changes, finding that they were often mistakenly identified as other types of tumors. All cases shared distinct physical characteristics and genetic markers that set them apart. This matters because recognizing these tumors correctly can improve diagnosis and treatment options for patients, as they may not respond the same way as more common tumor types.

Plain English
This study looked at the challenges that new pathologists face when they start working independently after their training. Researchers surveyed 12 pathologists at three different times: right before they started their jobs and again at 6 months and 12 months into their new roles. They found that while these new pathologists became more comfortable and confident over time, they still reported struggles such as managing heavy case loads, handling cases outside their specialty, and balancing teaching with their work. Who this helps: This benefits early career pathologists and their employers, such as hospitals and clinics.

Plain English
This study looked at ovarian sex cord-stromal tumors, which are rare tumors that can be hard to diagnose. Researchers discussed their characteristics, how they can appear in different ways, and updated information about the genetic and molecular links to other conditions. Understanding these tumors better helps doctors make more accurate diagnoses and improve treatment plans. Who this helps: This benefits patients diagnosed with ovarian tumors and their doctors.

Plain English
This study looks at rare types of ovarian tumors called sex cord-stromal tumors, focusing on their unique characteristics and recent findings. The researchers found that these tumors can have unusual appearances and specific molecular traits that can complicate their diagnosis, highlighting the importance of understanding them better. This knowledge is crucial because it can lead to improved diagnosis and treatment strategies for affected patients. Who this helps: Patients with sex cord-stromal tumors and their doctors.

Plain English
The study examined a virtual learning program called a journal club that focused on gynecologic pathology over two years. This program included 59 speakers, mainly early-career pathologists, who discussed 71 research articles and attracted 827 live attendees along with over 16,000 views of recorded sessions. The initiative aimed to provide mentorship and inclusion, and the feedback showed it helped improve medical knowledge and communication skills for those involved. Who this helps: This benefits trainees and early-career pathologists worldwide.

Plain English
This study focused on a type of uterine cancer called uterine serous carcinoma (USC), which is known for being particularly aggressive and deadly. Researchers found that high levels of a protein called Galectin 3 (Gal3) in patients with USC are linked to worse outcomes; specifically, patients with low Gal3 levels had reduced tumor progression. By using techniques to block Gal3, the researchers observed decreased tumor growth and reduced tumor characteristics in laboratory tests, suggesting that targeting Gal3 could improve treatment for USC. Who this helps: This research benefits patients with uterine serous carcinoma by potentially leading to new treatment options.

Plain English
This study focused on a rare type of uterine tumor called inflammatory myofibroblastic tumors (IMTs) to find out if a protein called p16 can help predict how aggressive the tumor is. Researchers analyzed 30 tumors and found that 15 were malignant, with a higher likelihood of bad outcomes, like recurrence, over the follow-up period (median 24 months). They discovered that p16 behaved differently in malignant tumors compared to benign ones, suggesting that testing for p16 could be a helpful and cost-effective way to predict tumor behavior and guide treatment. Who this helps: This research benefits doctors and patients with uterine tumors by providing better tools for diagnosis and treatment planning.

Plain English
This study focused on a rare type of ovarian tumor called Sertoli-Leydig cell tumors (SLCTs) and looked at factors influencing survival and outcomes for patients. Out of 191 patients studied, 93.6% of those with early-stage tumors (stage IA) remained free of recurrence after three years, while those with more advanced stages had significantly lower rates of 67.1% and 60.6%. Understanding these outcomes is important because it helps identify patients at higher risk of their cancer returning, particularly those with specific features of the tumor. Who this helps: This information benefits patients and doctors by guiding treatment decisions and improving monitoring strategies.

Plain English
This study looked at high-grade endometrial cancer, which is often overlooked in research despite its seriousness. It found that using molecular testing can improve treatment options, especially for patients whose cancer is resistant to standard drugs. By combining different therapies, researchers see promising results that could lead to more effective and safer treatments for patients. Who this helps: Patients with high-grade endometrial cancer and their doctors.

Plain English
This study looked at 20 cases of peritoneal inclusion cysts (PICs), which are fluid-filled sacs in the abdomen. Researchers found that even larger and more complex PICs, which raised some concerns for cancer, did not show any genetic changes that would indicate malignancy and were generally associated with good outcomes, with only two cases experiencing local recurrences after a year and a half. This is significant because it reassures both patients and doctors that these cysts, even if large, are typically benign and do not lead to serious health issues. Who this helps: This helps patients dealing with peritoneal inclusion cysts and their doctors in understanding the likely outcomes.

Plain English
This study looked at the presence of embryoid bodies, a specific cell structure, in different types of ovarian tumors, including 100 immature teratomas and 125 malignant mixed germ cell tumors. Researchers found that only a small number—about 3% of immature teratomas—had well-formed embryoid bodies, while 14% had remnants that were linked to more aggressive tumor types. In malignant mixed tumors, 25% showed these remnants, often accompanying other poorly differentiated cancer types, indicating that these tumors are complex and potentially more dangerous. Who this helps: This research benefits doctors and oncologists in better understanding and diagnosing ovarian germ cell tumors.

Plain English
This study looks at a 10-year-old girl with Ollier disease who had an ovarian tumor. The tumor was found to be a rare mixed sex-cord stromal tumor, which has not previously been linked to Ollier disease, and genetic testing showed a specific mutation called IDH1. This research increases our understanding of the types of tumors that can occur in patients with genetic conditions, helping doctors better monitor and screen for similar cases in the future. Who this helps: Patients with rare genetic disorders and their doctors.

Plain English
This study looked at three markers (BAP1, Claudin-4, and MTAP) to see if they could help doctors tell the difference between peritoneal mesothelioma (PM), a type of cancer, and low-grade serous ovarian tumors. The researchers found that 67% of PM samples had lost BAP1, while all serous tumors retained it; Claudin-4 was found in all serous tumors but none of the PM samples. This is important because accurately differentiating these conditions can influence treatment decisions and patient outcomes. Who this helps: This helps patients with suspected ovarian tumors or mesothelioma by improving diagnostic accuracy.

Plain English
This study looked at unusual cysts called Walthard nests found in the diaphragm of three women (aged 25, 36, and 39) during surgeries for suspected endometriosis. The researchers found small, pearly white nodules that had cyst-like spaces and specific cell types when examined closely. It's important to recognize these findings during surgery because they can be mistaken for other conditions, which could lead to misdiagnosis. Who this helps: This helps doctors and their patients, particularly those with endometriosis, by improving understanding and diagnosis of unusual cysts.

Plain English
This study focused on rare uterine tumors called inflammatory myofibroblastic tumors (IMTs) that can look like benign fibroid tumors (leiomyomas) when they return after treatment. Three patients, aged 34, 43, and 45, were observed, and it was found that two of them had classic tumor features while one had a leiomyoma-like appearance. Notably, the treatments with a specific medication (crizotinib) resulted in a long-term remission for one patient, highlighting the importance of testing for ALK gene alterations in these cases. Who this helps: This benefits patients with recurrent uterine tumors by guiding more effective treatment options.

Plain English
This study looked at a rare type of uterine cancer called endometrial stromal tumors that have a specific gene fusion (YWHAE::NUTM2) but appear low-grade under the microscope. Researchers found five cases, with patients aged 30 to 51, and noted that two of them developed aggressive tumors later on, with one dying just five months after a high-grade recurrence. This matters because it shows that even tumors that seem low-grade can become more dangerous, highlighting the need for better testing to catch these cases early. Who this helps: This information benefits doctors and patients dealing with endometrial stromal tumors.

Plain English
This study looked at a rare type of ovarian tumors called sex cord-stromal tumors (OSCSTs), which can be either non-cancerous or cancerous. It found that these tumors often occur in younger women and are usually diagnosed at an earlier stage, leading to better outcomes compared to more common types of ovarian cancer. The research highlights the importance of using imaging techniques to help identify these tumors, which can help doctors make quicker and more accurate diagnoses. Who this helps: This benefits patients, particularly younger women with ovarian tumors.

Plain English
This study looked at 70 cases of ovarian tumors known as sex cord-stromal tumors to understand the role of sclerosis, a hardening of tissue, in these tumors. They found that sclerosis made up between 20% to 95% of the tumors, which often made it difficult to identify them correctly; for instance, 31 tumors presented a misleading appearance that could be mistaken for other types. Recognizing how much sclerosis is present in these tumors is important for accurate diagnosis, especially during surgeries when only small samples are available. Who this helps: This helps pathologists and surgeons by improving their ability to diagnose ovarian tumors accurately.

Plain English
This study looked at how the spread of cancer cells in the lymphatic system affects the survival of patients with cervical squamous cell carcinoma (SCC) after surgery. Researchers analyzed 670 tumor samples and found that 51% of patients had lymphovascular invasion (LVI), with extensive LVI being linked to significantly worse outcomes, increasing the risk of progression-free survival by 2.38 times compared to those without LVI. This information is important because understanding the extent of LVI could help doctors better predict patient outcomes and guide treatment decisions. Who this helps: Patients with cervical cancer and their doctors.

Plain English
This research studied a rare type of cervical cancer called HPV-independent squamous cell carcinoma (HPVI SCC) by examining 670 patients. It found that only 2% of these patients had HPVI SCC; however, the rate was higher in older patients, reaching 7% in those over 60 and 17% in those over 70. Patients with HPVI SCC were older and more likely to be diagnosed at a later stage compared to those with the more common HPV-associated cancers. Who this helps: This study helps doctors understand a rare type of cervical cancer, particularly in older patients, to improve diagnosis and treatment strategies.

Plain English
This study looked at 100 cases of a rare but benign type of ovarian tumor called sclerosing stromal tumor (SST), which mostly affects younger women. The tumors varied in size from 1 to 23 centimeters, with a typical average size of about 8.4 centimeters. Key findings included that 14 patients were pregnant, and most tumors showed features like a mix of different cell types and a lot of blood vessels, which help doctors identify and differentiate SST from other similar tumors. Who this helps: This information benefits doctors and gynecologists diagnosing ovarian tumors.

Plain English
This study examined 27 cases of solitary fibrous tumors in the female genital tract, focusing on their locations outside the vulva and their various characteristics. Researchers found that these tumors ranged in size from 1.5 to 39 centimeters, with 7 being classified as malignant. Out of those monitored for recurrence during a median follow-up of 23 months, 6 tumors came back, and one even spread to the lung, highlighting the need for careful monitoring and diagnosis of these tumors. Who this helps: This helps patients and doctors by improving diagnosis and treatment plans for women with these tumors.

Plain English
This study explored a specific group of blood disorders called myelodysplastic/myeloproliferative neoplasms (MDS/MPN) that have a genetic abnormality known as isochromosome 17q. Researchers analyzed 92 cases and found that about 32% had this abnormality. Patients with this genetic marker were generally younger and had worse outcomes, living an average of only 11 months compared to 28 months for those without it, highlighting a need for tailored treatment approaches. Who this helps: This helps doctors and researchers better understand and treat patients with this specific blood disorder.

Plain English
This study looked at 94 cases of a rare cancer called embryonal rhabdomyosarcoma in the cervix, mostly affecting young patients with a median age of 23. The researchers found that many patients had symptoms like vaginal bleeding or a mass, and those with a genetic condition called DICER1 syndrome tended to be younger and had better outcomes, with none dying from the disease. This matters because understanding the various features and behaviors of this cancer can help doctors provide better diagnoses and treatment options, especially using a less aggressive approach when appropriate. Who this helps: This helps patients with cervical rhabdomyosarcoma and their doctors in making informed treatment decisions.

Plain English
This study looked at how early cancer cells from the fallopian tubes spread to the ovaries in high-grade serous ovarian cancer. Researchers found that a protein called L1CAM helps these cancer cells detach from the fallopian tubes and survive as they move to the ovaries, making it easier for them to grow into tumors. Understanding this process is important because it could lead to new ways to prevent or treat ovarian cancer by targeting the mechanisms that allow cancer cells to spread. Who this helps: This helps patients at risk for ovarian cancer.

Plain English
This study looked at how certain cancers of the ovaries and uterus (often resistant to common treatments) respond to a new combination therapy that targets specific proteins involved in cell growth. Researchers found that cancers with a high number of specific gene copies were more sensitive to this treatment, leading to significant tumor reductions and better survival rates. Specifically, the therapy caused a marked increase in cell death and reduced cancer cell growth in models that represent actual patient tumors. Who this helps: This benefits patients with advanced ovarian and endometrial cancers who need more effective treatment options.

Plain English
This research paper examines the role of human papilloma virus (HPV) in various types of cancers that develop in the head and neck area, particularly highlighting new findings related to these cancers' characteristics. The study shows that HPV significantly contributes to most head and neck cancers, including recently identified forms in the nasal passages and around the eyes. Understanding these connections is important for improving diagnosis and treatment strategies for affected patients. Who this helps: This helps patients with HPV-related head and neck cancers and their doctors.